{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:45:17Z","timestamp":1791297917068,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.cld.2012.11.002","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T21:22:30Z","timestamp":1356038550000},"page":"191-209","source":"Crossref","is-referenced-by-count":67,"title":["Drug-Induced Cholestasis"],"prefix":"10.1016","volume":"17","author":[{"given":"Einar S.","family":"Bjornsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Gunnlaugur","family":"Jonasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2012.11.002_bib1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugs\u2013II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge","volume":"46","author":"Benichou","year":"1993","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cld.2012.11.002_bib2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2013I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cld.2012.11.002_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-0029-1240005","article-title":"The pathology of drug-induced liver injury","volume":"29","author":"Kleiner","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2012.11.002_bib4","series-title":"Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver","author":"Zimmerman","year":"1999"},{"key":"10.1016\/j.cld.2012.11.002_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bjornsson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.1840200610","article-title":"Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis","volume":"20","author":"Moradpour","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.22442","article-title":"Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury","volume":"48","author":"Rochon","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib8","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/hep.23577","article-title":"Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method","volume":"51","author":"Rockey","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0029-1240003","article-title":"Causality assessment in drug-induced liver injury","volume":"29","author":"Hayashi","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2012.11.002_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MEG.0b013e32832b8e10","article-title":"Stevens-Johnson syndrome and cholestatic hepatitis induced by acute Epstein-Barr virus infection","volume":"23","author":"Maggio","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1476-0711-10-35","article-title":"Cholestatic hepatitis in a patient with typhoid fever - a case report","volume":"10","author":"Ratnayake","year":"2011","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.cld.2012.11.002_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5009\/gnl.2009.3.2.141","article-title":"A\u00a0case of acute q Fever with severe acute cholestatic hepatitis","volume":"3","author":"Choi","year":"2009","journal-title":"Gut Liver"},{"key":"10.1016\/j.cld.2012.11.002_bib13","first-page":"1267","article-title":"Weight loss and severe jaundice in a patient with hyperthyroidism","volume":"49","author":"Breidert","year":"2011","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.002_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/313680","article-title":"Trovafloxacin-induced acute hepatitis","volume":"30","author":"Lucena","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cld.2012.11.002_bib16","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/hep.22272","article-title":"Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury (DILI). Search for signals","volume":"47","author":"Lammert","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib17","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.22895","article-title":"Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and gender","volume":"49","author":"Lucena","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/hep.23317","article-title":"Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events","volume":"51","author":"Lammert","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jhep.2010.12.041","article-title":"Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis","volume":"55","author":"Lucena","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish Registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.002_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21214","article-title":"Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver","volume":"44","author":"Meier","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0016-5085(97)70193-8","article-title":"Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease","volume":"113","author":"Leevy","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.002_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF02598014","article-title":"Hepatobiliary complications of oral contraceptives","volume":"7","author":"Lindberg","year":"1992","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.cld.2012.11.002_bib24","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.002_bib25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.50.3.436","article-title":"Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis","volume":"50","author":"Prince","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.11.002_bib26","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0016-5085(99)70404-X","article-title":"HLA association of\u00a0amoxicillin-clavulanate\u2013induced hepatitis","volume":"117","author":"Hautekeete","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.002_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/gut.47.5.717","article-title":"Co-amoxiclav jaundice: clinical and histological features and HLA class II association","volume":"47","author":"O\u2019Donohue","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.11.002_bib28","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/hep.20215","article-title":"HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease","volume":"39","author":"Andrade","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.cld.2012.11.002_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3748\/wjg.14.38","article-title":"Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump","volume":"14","author":"Meier","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"6127","key":"10.1016\/j.cld.2012.11.002_bib31","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.1.6127.1591","article-title":"Primary biliary cirrhosis after long-term practolol administration","volume":"1","author":"Brown","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.cld.2012.11.002_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4065\/73.3.285","article-title":"Idiopathic adulthood ductopenia: an update","volume":"73","author":"Ludwig","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cld.2012.11.002_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hep.1840150212","article-title":"Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia","volume":"15","author":"Degott","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0168-8278(92)90029-O","article-title":"Liver damage from flucloxacillin, cloxacillin and dicloxacillin","volume":"15","author":"Olsson","year":"1992","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-8278(97)82330-6","article-title":"Vanishing bile duct syndrome in drug-induced liver disease","volume":"26","author":"Desmet","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0168-8278(05)80476-3","article-title":"Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis","volume":"20","author":"Davies","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib37","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/0016-5085(92)90780-3","article-title":"Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome","volume":"102","author":"Forbes","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.002_bib38","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/00042737-200209000-00014","article-title":"Reversible vanishing bile duct syndrome induced by carbamazepine","volume":"14","author":"Ramos","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib39","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib40","first-page":"194","article-title":"Chronic cholestasis following prolonged tolbutamide administration","volume":"84","author":"Gregory","year":"1967","journal-title":"Arch Pathol"},{"key":"10.1016\/j.cld.2012.11.002_bib41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.1968.03140150074026","article-title":"Biliary cirrhosis following administration of methyltestosterone","volume":"204","author":"Glober","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2012.11.002_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1600-0676.1993.tb00635.x","article-title":"A\u00a0case of drug-induced ductopenia resulting in fatal biliary cirrhosis","volume":"13","author":"Ishii","year":"1993","journal-title":"Liver"},{"key":"10.1016\/j.cld.2012.11.002_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/00313029309066576","article-title":"Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy","volume":"25","author":"Eckstein","year":"1993","journal-title":"Pathology"},{"key":"10.1016\/j.cld.2012.11.002_bib44","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/01.pas.0000213342.78475.48","article-title":"Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide","volume":"30","author":"Vuppalanchi","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cld.2012.11.002_bib45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI113355","article-title":"Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules","volume":"81","author":"Alpini","year":"1988","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2012.11.002_bib46","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJM185001020412204","article-title":"On hemorrhage from the umbilicus after the separation of the fetus","volume":"41","author":"Anderson","year":"1850","journal-title":"Boston Med Surg J"},{"key":"10.1016\/j.cld.2012.11.002_bib47","series-title":"MacSween's pathology of the liver","first-page":"75","article-title":"Basic mechanisms in hepatopathology","author":"Crawford","year":"2007"},{"key":"10.1016\/j.cld.2012.11.002_bib48","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","article-title":"Bile salt transporters: molecular characterization, function, and regulation","volume":"83","author":"Trauner","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cld.2012.11.002_bib49","series-title":"Biopsy interpretation of the liver","year":"2009"},{"key":"10.1016\/j.cld.2012.11.002_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2796.1992.tb00562.x","article-title":"Drug induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on adverse drug reactions between 1978 and 1987","volume":"232","author":"Friis","year":"1992","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cld.2012.11.002_bib51","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2007.03330.x","article-title":"The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury","volume":"25","author":"Bj\u00f6rnsson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.11.002_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.2008.058248","article-title":"Histological patterns in drug-induced liver disease","volume":"62","author":"Ramanchandran","year":"2009","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cld.2012.11.002_bib53","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/gut.33.3.368","article-title":"Hepatitis associated with amoxicillin-clavulanic acid combination: report of 15 cases","volume":"33","author":"Larrey","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.11.002_bib54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5858\/1999-123-0251-SICCBA","article-title":"Severe intrahepatic cholestasis caused by amiodarone toxicity after withdrawal of the drug: a case report and review of the literature","volume":"123","author":"Chang","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cld.2012.11.002_bib55","series-title":"Introduction to drug metabolism","author":"Gibson","year":"2001"},{"key":"10.1016\/j.cld.2012.11.002_bib56","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clpt.2005.05.011","article-title":"Transporters and drug therapy: implications for drug disposition and disease","volume":"78","author":"Ho","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.11.002_bib57","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.21359","article-title":"Hepatobiliary transporters and drug-induced cholestasis","volume":"44","author":"Pauli-Magnus","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib58","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhep.2005.03.017","article-title":"Enterohepatic transport of bile salts and genetics of cholestasis","volume":"43","author":"Pauli-Magnus","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib59","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/jhep.2002.34133","article-title":"Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver","volume":"36","author":"Vavricka","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib60","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/tx0002435","article-title":"Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes","volume":"14","author":"Lakehal","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.cld.2012.11.002_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/tx0002029","article-title":"Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity","volume":"14","author":"Iverson","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.cld.2012.11.002_bib62","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0016-5085(99)70356-2","article-title":"Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats","volume":"117","author":"Bolder","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.002_bib63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.11.002_bib64","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/jpet.106.119073","article-title":"Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP\/SLC10A1) by bosentan: a mechanism for species differences in hepatotoxicity","volume":"321","author":"Leslie","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.cld.2012.11.002_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","article-title":"Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury","volume":"17","author":"Lang","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.cld.2012.11.002_bib66","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","article-title":"Molecular pathogenesis of cholestasis","volume":"339","author":"Trauner","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2012.11.002_bib67","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0399-8320(04)95062-2","article-title":"Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs","volume":"28","author":"Biour","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cld.2012.11.002_bib68","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.002_bib69","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/00365520510023846","article-title":"Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden","volume":"40","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.002_bib70","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","article-title":"Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic","volume":"24","author":"De Valle","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.11.002_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.meg.0000250581.77865.68","article-title":"Antibiotic therapy: a major cause of drug-induced jaundice in southwest England","volume":"19","author":"Hussaini","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib72","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/hep.21324","article-title":"Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain","volume":"44","author":"Lucena","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib73","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/archinte.156.12.1327","article-title":"Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid","volume":"156","author":"Garc\u00eda Rodr\u00edguez","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cld.2012.11.002_bib74","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10620-005-2938-5","article-title":"Acute liver failure due to amoxicillin and amoxicillin\/clavulanate","volume":"50","author":"Fontana","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2012.11.002_bib75","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5694\/j.1326-5377.1989.tb139652.x","article-title":"Prolonged hepatic cholestasis after flucloxacillin therapy","volume":"151","author":"Turner","year":"1989","journal-title":"Med J Aust"},{"key":"10.1016\/j.cld.2012.11.002_bib76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/bmj.306.6872.233","article-title":"Risk factors for development of flucloxacillin associated jaundice","volume":"306","author":"Fairley","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.cld.2012.11.002_bib77","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cld.2007.06.009","article-title":"Hepatotoxicity due to antibiotics","volume":"11","author":"Polson","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2012.11.002_bib78","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1345\/aph.10266","article-title":"Benzylpenicillin-induced prolonged cholestasis","volume":"35","author":"Andrade","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cld.2012.11.002_bib79","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/clinids\/20.4.1073","article-title":"Clarithromycin-induced hepatotoxicity","volume":"20","author":"Brown","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cld.2012.11.002_bib80","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2146\/ajhp080687","article-title":"Azithromycin-induced liver injury","volume":"67","author":"Lockwood","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.cld.2012.11.002_bib81","first-page":"175","article-title":"Trimethoprim-sulfamethoxazole-associated hepatotoxicity - part of a hypersensitivity syndrome","volume":"10","author":"Mainra","year":"2003","journal-title":"Can J Clin Pharmacol"},{"issue":"5424","key":"10.1016\/j.cld.2012.11.002_bib82","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/bmj.2.5424.1545","article-title":"Tetracycline hepatotoxicity","volume":"2","author":"Anon","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/j.cld.2012.11.002_bib83","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/00365529709007690","article-title":"Liver reactions to oral low-dose tetracyclines","volume":"32","author":"Bj\u00f6rnsson","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.002_bib84","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2710.2007.00853.x","article-title":"Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study","volume":"32","author":"Heaton","year":"2007","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.cld.2012.11.002_bib85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1665-2681(19)32159-3","article-title":"Terbinafine hepatotoxicity. A case report and review of literature","volume":"2","author":"Zapata Garrido","year":"2003","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib86","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJM199904223401617","article-title":"Terbinafine and fulminant hepatic failure","volume":"340","author":"Agarwal","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2012.11.002_bib87","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0168-8278(95)80045-X","article-title":"Cholestatic hepatitis related to quinolones: a report of two cases","volume":"23","author":"Hautekeete","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib88","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0168-8278(02)00268-4","article-title":"Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn's disease","volume":"37","author":"Bataille","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib89","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/01.mcg.0000139074.40365.04","article-title":"Cephalexin-induced cholestatic hepatitis","volume":"38","author":"Skoog","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.002_bib90","first-page":"516A","article-title":"Cephalosporin induced liver injury: clinical and biochemical features","volume":"54","author":"Alqahtani","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib91","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00042737-200101000-00013","article-title":"Risperidone-induced cholestatic hepatitis","volume":"13","author":"Krebs","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib92","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1345\/aph.1K145","article-title":"Risperidone- and quetiapine-induced cholestasis","volume":"41","author":"Wright","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cld.2012.11.002_bib93","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1365-2036.2010.04449.x","article-title":"Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network","volume":"32","author":"Vuppalanchi","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.11.002_bib94","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1155\/1998\/294752","article-title":"Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity","volume":"12","author":"Romagnuolo","year":"1998","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.002_bib95","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s11096-010-9443-4","article-title":"Azathioprine-induced severe cholestatic hepatitis in patient carrying TPMT*3C polymorphism","volume":"32","author":"Ben Salem","year":"2010","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.cld.2012.11.002_bib96","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.dld.2009.03.004","article-title":"Severe cholestatic acute hepatitis following azathioprine therapy in a patient with ulcerative pancolitis","volume":"41","author":"Roda","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2012.11.002_bib97","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2036.2005.02636.x","article-title":"Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease","volume":"22","author":"Bastida","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.11.002_bib98","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1572-0241.2007.01187.x","article-title":"Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review","volume":"102","author":"Gisbert","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.002_bib99","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1517\/14740338.3.6.519","article-title":"Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity","volume":"3","author":"Aithal","year":"2004","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.cld.2012.11.002_bib100","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1872-034X.2007.00115.x","article-title":"Clinical and pathological features of a prolonged type of acute intrahepatic cholestasis","volume":"37","author":"Watanabe","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cld.2012.11.002_bib101","first-page":"385","volume":"36","author":"Hackstein","year":"1998","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.002_bib102","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0016-5085(98)70154-4","article-title":"Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child","volume":"115","author":"Srivastava","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.11.002_bib103","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1089-3261(03)00032-1","article-title":"Drug-induced cholestasis","volume":"7","author":"Levy","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2012.11.002_bib104","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.qai.0000243054.58074.59","article-title":"Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999)","volume":"43","author":"Servoss","year":"2006","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cld.2012.11.002_bib105","first-page":"825","article-title":"Jaundice in African-American and Hispanic patients with AIDS","volume":"99","author":"Akhtar","year":"2007","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.cld.2012.11.002_bib106","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.dld.2005.06.004","article-title":"Suspected drug-induced liver fatalities reported to the WHO database","volume":"38","author":"Bj\u00f6rnsson","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2012.11.002_bib107","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1111\/j.1572-0241.2007.01428.x","article-title":"Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV","volume":"102","author":"Schiano","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.11.002_bib108","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.cgh.2008.04.023","article-title":"Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection","volume":"6","author":"Saifee","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib109","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1086\/603559","article-title":"Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study","volume":"49","author":"Kovari","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cld.2012.11.002_bib110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.9734\/BJMMR\/2011\/554","article-title":"Didanosine exposure and noncirrhotic portal hypertension in a HIV Clinic in North America: a follow-up study","volume":"1","author":"Cachay","year":"2011","journal-title":"Br J Med Med Res"},{"key":"10.1016\/j.cld.2012.11.002_bib111","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13625189809167479","article-title":"Sex hormonal preparations and the liver","volume":"3","author":"Dourakis","year":"1998","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.cld.2012.11.002_bib112","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2796.1993.tb00745.x","article-title":"Liver damage from low-dose oral contraceptives","volume":"234","author":"Lindgren","year":"1993","journal-title":"J\u00a0Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2012.11.002_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(97)82326-4","article-title":"Drug-induced cholestasis","volume":"26","author":"Erlinger","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib114","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.cgh.2007.02.036","article-title":"Hepatotoxicity associated with dietary supplements containing anabolic steroids","volume":"5","author":"Kafrouni","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0029-1240006","article-title":"Herbal and dietary supplement hepatotoxicity","volume":"29","author":"Navarro","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2012.11.002_bib116","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0168-8278(02)00231-3","article-title":"Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs","volume":"37","author":"Ib\u00e1\u00f1ez","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2012.11.002_bib117","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.21424","article-title":"Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry","volume":"44","author":"Andrade","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2012.11.002_bib118","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2036.2007.03355.x","article-title":"Long-term follow-up of patients with mild to moderate drug-induced liver injury","volume":"26","author":"Bj\u00f6rnsson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2012.11.002_bib119","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jhep.2008.10.021","article-title":"The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice","volume":"50","author":"Bjornsson","year":"2009","journal-title":"J\u00a0Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112001407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112001407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T23:52:55Z","timestamp":1643932375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326112001407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1089326112001407"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2012.11.002","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}